Alector Appoints New CSO, Elects Director
Ticker: ALEC · Form: 8-K · Filed: Mar 21, 2024 · CIK: 1653087
| Field | Detail |
|---|---|
| Company | Alector, INC. (ALEC) |
| Form Type | 8-K |
| Filed Date | Mar 21, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-election, personnel
TL;DR
Alector shakes up leadership with a new CSO and board member.
AI Summary
Alector, Inc. announced on March 15, 2024, the appointment of Dr. Arnon Rosenthal as Chief Scientific Officer and the election of Dr. Sarah Hough as a new Class II director. The company also disclosed compensatory arrangements for certain officers, though specific dollar amounts were not detailed in this filing.
Why It Matters
Changes in key scientific and board leadership can signal shifts in a company's strategic direction and research priorities.
Risk Assessment
Risk Level: medium — Changes in executive and board positions can indicate internal shifts that may impact future performance.
Key Players & Entities
- Alector, Inc. (company) — Registrant
- Dr. Arnon Rosenthal (person) — Appointed Chief Scientific Officer
- Dr. Sarah Hough (person) — Elected Class II director
- March 15, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Scientific Officer at Alector, Inc.?
Dr. Arnon Rosenthal has been appointed as the new Chief Scientific Officer.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on March 15, 2024.
Who was elected as a new director to Alector, Inc.'s board?
Dr. Sarah Hough was elected as a new Class II director.
What is Alector, Inc.'s principal executive office address?
Alector, Inc.'s principal executive office is located at 131 Oyster Point Blvd., Suite 600, South San Francisco, California, 94080.
What is the SIC code for Alector, Inc.?
The Standard Industrial Classification (SIC) code for Alector, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 1,057 words · 4 min read · ~4 pages · Grade level 9.3 · Accepted 2024-03-21 16:01:29
Filing Documents
- d773925d8k.htm (8-K) — 26KB
- 0001193125-24-073821.txt ( ) — 146KB
- alec-20240315.xsd (EX-101.SCH) — 3KB
- alec-20240315_lab.xml (EX-101.LAB) — 18KB
- alec-20240315_pre.xml (EX-101.PRE) — 11KB
- d773925d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ALECTOR, INC. Date:March 21, 2024 By: /s/ Arnon Rosenthal Arnon Rosenthal, Ph.D. Co-founder and Chief Executive Officer